Cross-sector partnership launches EQBMED. Initially funded by PhRMA and established as a cross-sector collaborative, ...

In this video interview, Matt Robinson, PhD, senior director, oncology research program, National Comprehensive Cancer ...

Clinical trial processes lag behind scientific and technological advances. While the science and tools exist to run faster, more inclusive, and efficient trials, outdated mindsets, rigid protocols, ...

Clinical research evolves to prioritize patient-centered outcomes, integrating accessibility standards in electronic data ...

Clinical trials face a critical challenge: bridging the gap between patient curiosity and motivation to participate, ...

Joint Clinical Assessment is now a parallel requirement under HTAR. Health technology developers must prepare for a JCA ...

Recent analysis explores AI's momentum in drug development, showcasing rapid adoption and significant time savings, despite ...

In this video interview, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discusses ...

As stakeholders debate fair market value in clinical trial budgeting, a new task force works to align sponsors, CROs, and ...

Overcoming the illusion of knowledge in clinical research can enhance decision-making, training, and project success—helping ...

Phase III DeLLphi-304 results show T-cell engager Imdelltra (tarlatamab) delivers superior overall survival, improved ...

Phase II CONFIDENCE study data reveal that simultaneous initiation of Kerendia and Jardiance significantly improves UACR and ...